Tonix Pharmaceuticals Holding Corp.
NASDAQ:TNXP
Overview | Financials
Company Name | Tonix Pharmaceuticals Holding Corp. |
Symbol | TNXP |
Currency | USD |
Price | 0.37 |
Market Cap | 69,150,780 |
Dividend Yield | 0% |
52-week-range | 0.12 - 14.08 |
Industry | Biotechnology |
Sector | Healthcare |
CEO | Dr. Seth Lederman M.D. |
Website | https://www.tonixpharma.com |
An error occurred while fetching data.
About Tonix Pharmaceuticals Holding Corp.
Tonix Pharmaceuticals Holding Corp., a clinical-stage biopharmaceutical company, focuses on discovering, acquiring, developing, and licensing therapeutics and diagnostics to treat and prevent human disease and alleviate suffering. Its portfolio includes immunology, rare disease, infectious disease, and central nervous system (CNS) product candidates. The company's immunology portfolio includes biologics to address
Related Stocks
Financials
Numbers are in millions USD
Numbers are in millions USD